These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1204 related items for PubMed ID: 27731896

  • 21. Rates and predictors of starting a triptan: results from the American Migraine Prevalence and Prevention Study.
    Bigal ME, Buse DC, Chen YT, Golden W, Serrano D, Chu MK, Lipton RB.
    Headache; 2010 Oct; 50(9):1440-8. PubMed ID: 20533956
    [Abstract] [Full Text] [Related]

  • 22. Chronic rhinitis and its association with headache frequency and disability in persons with migraine: results of the American Migraine Prevalence and Prevention (AMPP) Study.
    Martin VT, Fanning KM, Serrano D, Buse DC, Reed ML, Bernstein JA, Lipton RB.
    Cephalalgia; 2014 Apr; 34(5):336-48. PubMed ID: 24275145
    [Abstract] [Full Text] [Related]

  • 23. Sex differences in the prevalence, symptoms, and associated features of migraine, probable migraine and other severe headache: results of the American Migraine Prevalence and Prevention (AMPP) Study.
    Buse DC, Loder EW, Gorman JA, Stewart WF, Reed ML, Fanning KM, Serrano D, Lipton RB.
    Headache; 2013 Sep; 53(8):1278-99. PubMed ID: 23808666
    [Abstract] [Full Text] [Related]

  • 24. Comorbid and co-occurring conditions in migraine and associated risk of increasing headache pain intensity and headache frequency: results of the migraine in America symptoms and treatment (MAST) study.
    Buse DC, Reed ML, Fanning KM, Bostic R, Dodick DW, Schwedt TJ, Munjal S, Singh P, Lipton RB.
    J Headache Pain; 2020 Mar 02; 21(1):23. PubMed ID: 32122324
    [Abstract] [Full Text] [Related]

  • 25. Predictors of allodynia in persons with migraine: Results from the Migraine in America Symptoms and Treatment (MAST) study.
    Dodick DW, Reed ML, Fanning KM, Munjal S, Alam A, Buse DC, Schwedt TJ, Lipton RB.
    Cephalalgia; 2019 Jun 02; 39(7):873-882. PubMed ID: 30732460
    [Abstract] [Full Text] [Related]

  • 26. Healthcare resource utilization and direct costs associated with frequent nausea in episodic migraine: results from the American Migraine Prevalence and Prevention (AMPP) Study.
    Lipton RB, Buse DC, Saiers J, Serrano D, Reed ML.
    J Med Econ; 2013 Jun 02; 16(4):490-9. PubMed ID: 23356422
    [Abstract] [Full Text] [Related]

  • 27. Evaluation of 2-Hour Post-Dose Efficacy of Lasmiditan for the Acute Treatment of Difficult-to-Treat Migraine Attacks.
    Tepper SJ, Vasudeva R, Krege JH, Rathmann SS, Doty E, Vargas BB, Magis D, Komori M.
    Headache; 2020 Sep 02; 60(8):1601-1615. PubMed ID: 32634275
    [Abstract] [Full Text] [Related]

  • 28. Predictors of First-Line Treatment Success in Children and Adolescents Visiting an Infusion Center for Acute Migraine.
    Orr SL, Kabbouche MA, Horn PS, O'Brien HL, Kacperski J, LeCates S, White S, Weberding J, Miller MN, Powers SW, Hershey AD.
    Headache; 2018 Sep 02; 58(8):1194-1202. PubMed ID: 29926909
    [Abstract] [Full Text] [Related]

  • 29. Impact of NSAID and Triptan use on developing chronic migraine: results from the American Migraine Prevalence and Prevention (AMPP) study.
    Lipton RB, Serrano D, Nicholson RA, Buse DC, Runken MC, Reed ML.
    Headache; 2013 Sep 02; 53(10):1548-63. PubMed ID: 23992516
    [Abstract] [Full Text] [Related]

  • 30. AVP-825 breath-powered intranasal delivery system containing 22 mg sumatriptan powder vs 100 mg oral sumatriptan in the acute treatment of migraines (The COMPASS study): a comparative randomized clinical trial across multiple attacks.
    Tepper SJ, Cady RK, Silberstein S, Messina J, Mahmoud RA, Djupesland PG, Shin P, Siffert J.
    Headache; 2015 May 02; 55(5):621-35. PubMed ID: 25941016
    [Abstract] [Full Text] [Related]

  • 31. Depression and risk of transformation of episodic to chronic migraine.
    Ashina S, Serrano D, Lipton RB, Maizels M, Manack AN, Turkel CC, Reed ML, Buse DC.
    J Headache Pain; 2012 Nov 02; 13(8):615-24. PubMed ID: 23007859
    [Abstract] [Full Text] [Related]

  • 32. Opioid use and dependence among persons with migraine: results of the AMPP study.
    Buse DC, Pearlman SH, Reed ML, Serrano D, Ng-Mak DS, Lipton RB.
    Headache; 2012 Jan 02; 52(1):18-36. PubMed ID: 22268775
    [Abstract] [Full Text] [Related]

  • 33. Framingham-Based Cardiovascular Risk Estimates Among People With Episodic Migraine in the US Population: Results from the American Migraine Prevalence and Prevention (AMPP) Study.
    Lipton RB, Reed ML, Kurth T, Fanning KM, Buse DC.
    Headache; 2017 Nov 02; 57(10):1507-1521. PubMed ID: 28990165
    [Abstract] [Full Text] [Related]

  • 34. Acute migraine medications and evolution from episodic to chronic migraine: a longitudinal population-based study.
    Bigal ME, Serrano D, Buse D, Scher A, Stewart WF, Lipton RB.
    Headache; 2008 Sep 02; 48(8):1157-68. PubMed ID: 18808500
    [Abstract] [Full Text] [Related]

  • 35. Frequency and burden of headache-related nausea: results from the American Migraine Prevalence and Prevention (AMPP) study.
    Lipton RB, Buse DC, Saiers J, Fanning KM, Serrano D, Reed ML.
    Headache; 2013 Jan 02; 53(1):93-103. PubMed ID: 23148774
    [Abstract] [Full Text] [Related]

  • 36. SumaRT/Nap vs naproxen sodium in treatment and disease modification of migraine: a pilot study.
    Cady R, O'Carroll P, Dexter K, Freitag F, Shade CL.
    Headache; 2014 Jan 02; 54(1):67-79. PubMed ID: 24021029
    [Abstract] [Full Text] [Related]

  • 37. Double-blind, placebo-controlled, crossover study of early-intervention with sumatriptan 85/naproxen sodium 500 in (truly) episodic migraine: what's neck pain got to do with it?
    Calhoun AH, Ford S.
    Postgrad Med; 2014 Mar 02; 126(2):86-90. PubMed ID: 24685971
    [Abstract] [Full Text] [Related]

  • 38. A Real-World Analysis of Patient Characteristics, Treatment Patterns, and Level of Impairment in Patients With Migraine Who are Insufficient Responders vs Responders to Acute Treatment.
    Lombard L, Ye W, Nichols R, Jackson J, Cotton S, Joshi S.
    Headache; 2020 Jul 02; 60(7):1325-1339. PubMed ID: 32510611
    [Abstract] [Full Text] [Related]

  • 39. Clinical Pain Catastrophizing in Women With Migraine and Obesity.
    Bond DS, Buse DC, Lipton RB, Thomas JG, Rathier L, Roth J, Pavlovic JM, Evans EW, Wing RR.
    Headache; 2015 Jul 02; 55(7):923-33. PubMed ID: 26087348
    [Abstract] [Full Text] [Related]

  • 40. Assessing Barriers to Chronic Migraine Consultation, Diagnosis, and Treatment: Results From the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study.
    Dodick DW, Loder EW, Manack Adams A, Buse DC, Fanning KM, Reed ML, Lipton RB.
    Headache; 2016 May 02; 56(5):821-834. PubMed ID: 27143127
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 61.